BioRestorative Therapies gets Nasdaq notice over late filing of quarterly report
BRTX•Nasdaq delinquency notice for late quarterly filing
BioRestorative Therapies received a Nasdaq delinquency notice on Aug. 21, 2026 for failing to timely file its quarterly Form 10-Q.
Non-compliance was cited under Nasdaq Listing Rule 5250(c)(1), which requires timely SEC periodic financial reporting.
Nasdaq listing remains in place, with shares continuing to trade on the Nasdaq Capital Market under BRTX.
The deadline to submit a compliance plan is Oct. 20, 2026; Nasdaq could grant time to regain compliance until Feb. 16, 2027.
Rejection of the plan would trigger an appeal path to a Nasdaq Hearings Panel.
